'Global primary biliary cholangitis' presentation slideshows

The Global Primary Biliary Cholangitis Therapeutics Market Size 2019 to witness a CAGR of close to 10% during the foreca

The global primary biliary cholangitis therapeutics market size is projected to grow by USD 241.28 million during 2019-2023 at a CAGR of close to 10%, with OCALIVA having the largest market share. The global primary biliary cholangitis therapeutics market analysis indicates that the growth will be driven by growing awareness campaigns to reduce further complications. The Advent of regenerative therapy will also influence the primary biliary cholangitis therapeutics industry growth.

37 views • 3 slides